Ligand Pharmaceuticals IncorporatedLigand Pharmaceuticals IncorporatedLigand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

No trades
No trades
Previous close
Open
Volume
Dividend yield (indicated)

Details


CEO
Todd Christopher Davis
Website
Headquarters
Jupiter
Founded
1987
ISIN
US53220K1997
CUSIP
53220K199
FIGI
BBG000S8JKX0
Identifiers
ISIN US53220K1997
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.